Stock Developments for Tuesday, September 23, 2008: Pluristem Therapeutics Inc. (NasdaqCM: PSTI), Funding At A Premium!

September 23, 2008 (M2 PRESSWIRE via COMTEX) — TheSUBWAY.com: Names the following stocks to its Stock Alerts List: Pluristem Therapeutics Inc. (Nasdaq: PSTI), Juniper Networks, Inc. (NASDAQ:JNPR), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), Broadcom Corporation (Nasdaq: BRCM), Altera Corporation (NASDAQ:ALTR), Morgan Stanley (NYSE: MS).

Visit TheSUBWAY’s Small Cap Investor Forum Here: http://investor-forum.thesubway.com/

Pluristem Therapeutics Inc. (NasdaqCM:PSTI), a bio-therapeutics company dedicated to the commercialization of non-personalized cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced it has entered into definitive agreements to sell common stock and warrants for aggregate gross proceeds of $1,035,000.  This represents a premium of over 44% to the current market price.

The securities sold in the offering were 900,000 shares of common stock at a price of $1.15 per share and a five-year warrant to purchase 675,000 shares of common stock at an exercise price of $1.90 per share.

Technical analysts believe a narrowing of the Bollinger Bands around a Company’s stock price suggests a significant movement will soon occur.  With PSTI, the bands could not be any narrower.  The last two times they approached this level, the stock saw an upswing of over 216% and 60% in share price.

Other stocks highlighted include:

Juniper Networks, Inc. (NASDAQ:JNPR), up 1% on 4 million shares, , the leader in high-performance networking, announced today its continued commitment to understanding and documenting its environmental impact by sponsoring and participating in the Carbon Disclosure Project (CDP), which launched its sixth report, CDP6, today in New York City. CDP is a global standardized mechanism by which companies report their greenhouse gas emissions to institutional investors; it hosts one of the largest registries of corporate greenhouse gas data in the world at www.cdproject.net.

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), down 2% on 5 million shares, Friday announced presentations of several new studies at the World Congress on Treatment and Research in Multiple Sclerosis in Montreal. New data will be presented on COPAXONE (glatiramer acetate injection), a leading therapy for relapsing-remitting multiple sclerosis (RRMS) treatment, covering early treatment with COPAXONE , long-term efficacy and safety.

Broadcom Corporation (Nasdaq: BRCM), down 1% on 3 million shares, a global leader in semiconductors for wired and wireless communications, today announced the industry’s first family of 65 nanometer (nm) 10 Gigabit (10G) physical layer (PHY) devices that support data rates ranging from 9.953 Gigabits per second (Gbps) to 11.35 Gbps. Combining the industry’s lowest power consumption with industry-leading long reach jitter performance, these next generation PHYs are fully integrated, Multi Source Agreement (MSA)-compliant devices that support multi-rate applications including OC-192 SONET/SDH, 10 Gigabit Ethernet (10GbE), 10G Fibre Channel (10FC), and optical transport networks (OTN).

Altera Corporation (NASDAQ:ALTR), down 2% on 2 million shares, today announced the availability of a 10-gigabit Ethernet (10GbE) reference design targeting designers using the XAUI communications protocol. Line cards and system controllers used within network routers, enterprise and metro Ethernet switches, and storage switches can leverage Altera’s Arria and Stratix series of FPGAs to connect reliably to 10GbE backplanes or networks. Altera’s 10GbE solution is IEEE 802.3ae standard compliant and successfully passed the University of New Hampshire Interoperability Lab (UNH-IOL) 10GbE tests.

Morgan Stanley (NYSE: MS),  today announced that it has entered into a letter of intent to pursue a strategic alliance with Mitsubishi UFJ Financial Group, Inc., Japan’s largest banking group and the world’s second largest bank holding company with $1.1 trillion in bank deposits. The letter of intent relates to an investment in Morgan Stanley that would eventually reach 20 percent of its equity on a fully diluted basis. The investment would be based on Morgan Stanley’s book value as agreed upon completion of satisfactory due diligence. Upon the closing, a representative of MUFG will join the Morgan Stanley board.

ABOUT TheSUBWAY.com:

TheSUBWAY.com, a leader in corporate communications and finance, provides all investors with a wide-ranging set of financial tools, including original stock market commentary, stock quotes, interactive charts, portfolio watch, live chat and message boards, etc., plus the latest news, press releases, investment opinions, and research reports for all companies highlighted on the site. For more daily commentary, go to http://www.thesubway.com

TheSubway.com is consistently ranked in the top 4 on the StockPromoters.com “Best performing promoters of all time” list. This is out of over 1,000 promoters and promotional campaigns tracked by StockPromoters.com. Visit http://www.StockPromoters.com for more details.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRGP has been compensated forty thousand shares for PSTI.  CRGP intends to sell its shares.  CRGP and its web site are operated under a license from Capital Research Group, Inc., TheSUBWAY.com Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP’s affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

CONTACT: Joe Farrar, President, CRG Partners, Inc Tel: +1 973 332 1366 WWW: http://www.TheSUBWAY.com